We are live on ! Find out more
NVRO

NEVRO CORP.
NVRO

Delisted

NVRO was delisted on the 2nd of April, 2025.

Back to rankings

177 hedge funds and large institutions have $1.63B invested in NEVRO CORP. in 2022 Q3 according to their latest regulatory filings, with 28 funds opening new positions, 58 increasing their positions, 60 reducing their positions, and 27 closing their positions.

New
Increased
Maintained
Reduced
Closed

7% more capital invested

Capital invested by funds: $1.52B → $1.63B (+$113M)

4% more first-time investments, than exits

New positions opened: 28 | Existing positions closed: 27

1% more funds holding

Funds holding: 176 → 177 (+1)

3% less repeat investments, than reductions

Existing positions increased: 58 | Existing positions reduced: 60

11% less call options, than puts

Call options by funds: $29.1M | Put options by funds: $32.7M

Holders
177
Holders Change
+1
Holders Change %
+0.57%
% of All Funds
3.05%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
28
Increased
58
Reduced
60
Closed
27
Calls
$29.1M
Puts
$32.7M
Net Calls
-$3.64M
Net Calls Change
-$3.33M

Top Buyers

1
Fidelity Investments
Fidelity Investments
Massachusetts
+$150M
2
Millennium Management
Millennium Management
New York
+$13.1M
3
JP Morgan Chase
JP Morgan Chase
New York
+$10.3M
4
Adage Capital Partners
Adage Capital Partners
Massachusetts
+$9.28M
5
PAMP
Polar Asset Management Partners
Ontario, Canada
+$8.18M

Top Sellers

1
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$33.8M
2
Franklin Resources
Franklin Resources
California
-$30.5M
3
Marshall Wace
Marshall Wace
United Kingdom
-$22.8M
4
Victory Capital Management
Victory Capital Management
Texas
-$20.8M
5
RG
Redmile Group
California
-$17.8M
Name Holding Trade Value Shares
Change 		Change in
Stake
Northern Trust
26
Northern Trust
Illinois
$14.8M -$133K -2,864 -0.9%
T. Rowe Price Associates
27
T. Rowe Price Associates
Maryland
$13.5M -$33.8M -728,899 -72%
Millennium Management
28
Millennium Management
New York
$13.1M +$13.1M +281,730 New
BG
29
Bellevue Group
Switzerland
$12.2M -$209K -4,504 -2%
Charles Schwab
30
Charles Schwab
California
$11.9M +$286K +6,168 +2%
Capital World Investors
31
Capital World Investors
California
$11.8M – – –
PAMS
32
Pictet Asset Management (Switzerland)
Switzerland
$11.7M +$30.2K +650 +0.3%
Citadel Advisors
33
Citadel Advisors
Florida
$10.6M -$2.24M -48,299 -17%
PAMP
34
Polar Asset Management Partners
Ontario, Canada
$10.5M +$8.18M +176,200 +363%
Jennison Associates
35
Jennison Associates
New York
$9.71M +$42.5K +915 +0.4%
Adage Capital Partners
36
Adage Capital Partners
Massachusetts
$9.32M +$9.28M +200,000 New
BNP Paribas Asset Management
37
BNP Paribas Asset Management
France
$9.28M +$1.14M +24,504 +14%
Marshall Wace
38
Marshall Wace
United Kingdom
$8.68M -$22.8M -490,779 -72%
Voloridge Investment Management
39
Voloridge Investment Management
Florida
$8.39M -$5.62M -121,093 -40%
Lazard Asset Management
40
Lazard Asset Management
New York
$8.38M -$2.06M -44,403 -20%
Deutsche Bank
41
Deutsche Bank
Germany
$7.62M +$1.9M +40,902 +33%
JG
42
Jefferies Group
New York
$7.29M +$298K +6,412 +4%
Assenagon Asset Management
43
Assenagon Asset Management
Luxembourg
$7.06M -$9.5M -204,643 -57%
PA
44
Perceptive Advisors
New York
$6.99M +$6.96M +150,000 New
Bank of New York Mellon
45
Bank of New York Mellon
New York
$6.98M -$8.52M -183,483 -55%
N
46
Nuveen
North Carolina
$6.2M -$190K -4,086 -3%
Bank of America
47
Bank of America
North Carolina
$6.17M -$2.55M -55,013 -29%
Capital Fund Management (CFM)
48
Capital Fund Management (CFM)
France
$5.17M +$205K +4,426 +4%
IHAM
49
Integral Health Asset Management
New York
$4.66M +$1.01M +21,723 +28%
Jacobs Levy Equity Management
50
Jacobs Levy Equity Management
New Jersey
$4.36M -$131K -2,831 -3%
1
2
3 4 5

NVRO Hedge Fund Activity: Q3 2022 in Review

177 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in NEVRO CORP. (NVRO) for Q3 2022, worth a combined $1.63B — up 7.5% from $1.52B a quarter earlier.

Buyers outnumbered sellers: 28 funds opened new NVRO positions and 27 closed out — a net gain of 1 holder — while 58 added to existing stakes and 60 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $150M. The largest seller was T. Rowe Price Associates, cutting an estimated $33.8M.

  • 177 institutional investors held NEVRO CORP. (NVRO) as of Q3 2022, up from 176 in Q2 2022.
  • Funds reported $1.63B of NEVRO CORP. stock for Q3 2022, up 7.5% quarter-over-quarter.
  • 28 funds opened new NEVRO CORP. positions in Q3 2022 and 27 closed out, a net change of +1 holder.
  • The largest NEVRO CORP. buyer in Q3 2022 was Fidelity Investments, an estimated $150M added.
  • The largest NEVRO CORP. seller in Q3 2022 was T. Rowe Price Associates, an estimated $33.8M sold.

Based on aggregated 13F filings for Q3 2022.